Back to homepage

Endocrinology

Advances in safe insulin infusions

Authors: Fred Massoomi, Maureen Burger, Christine de Vries

This narrative review explores the expanding indications, risks and opportunities associated with insulin infusions and potential options for improved safety.

More▸

Ertugliflozin in the treatment of type 2 diabetes mellitus

Authors: Joel C Marrs PharmD, MPH, Sarah L Anderson PharmD

This narrative review aims to present and discuss the efficacy, safety, cardiovascular, and renal outcomes related to the use of ertugliflozin in Type 2 diabetes.

More▸

Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?

Authors: Louise Statham MPharm, PGClin Dip, PGCHE, IPresc, Sharon Abdy RN, BSc (Hons), Terry J Aspray MBBS, MD, FRCP, FRCP(Edinburgh)

The aim of this study was to analyse changes in C-terminal telopeptide on stopping long-term blood pressures in a real-world population to see whether
persistence of BP effect was maintained.

More▸

Management of type 2 diabetes: consensus of diabetes organizations

Authors: Elaena Quattrocchi BS, PharmD, FASHP, CDE, Tamara Goldberg BS, PharmD, BCPS, Nino Marzella BS, MS, PharmD

This article reviews the recommendations of different diabetes organizations for achieving glycemic control.

More▸

Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review

Authors: Zhiheng H He MD, PhD, Yan Li MD, Nitin Trivedi MD, Sabrina Gill MD, James V Hennessey MD

Excessive exogenous thyroid hormone ingestion may lead to severe thyrotoxicosis and cause potential harm; this review of the literature suggests that thyroid hormone supplementation should not be used to alleviate nonspecific complaints in patients with normal endogenous thyroid function.

More▸